


Ask a doctor about a prescription for DONEPEZIL TARBIS 5 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Donepezil Tarbis 5 mg Film-Coated Tablets EFG
Donepezil Hydrochloride Monohydrate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Donepezil Tarbis belongs to a group of medicines called specific and reversible inhibitors of acetylcholinesterase, the predominant cholinesterase in the brain.
It is used in the symptomatic treatment of mild to moderately severe Alzheimer's disease.
Do not take Donepezil Tarbis
Warnings and precautions
Consult your doctor or pharmacist before starting to take Donepezil Tarbis
Using Donepezil Tarbis with other medicines
In particular, it is important that you inform your doctor if you are taking any of the following types of medicines:
The individual effect of donepezil cannot be predicted, so the effect of treatment should be regularly evaluated by your doctor.
Taking Donepezil Tarbis with food, drinks, and alcohol
Taking donepezil with alcohol may reduce the absorption of this medicine. You should avoid drinking alcohol while being treated with donepezil.
Children:
The use of donepezil is not recommended in children.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take Donepezil Tarbis if you are pregnant.
Do not take Donepezil Tarbis if you are breastfeeding.
Driving and using machines
Your illness may affect your ability to drive or use machines, and you should not carry out these activities unless your doctor tells you it is safe to do so. Donepezil may cause dizziness and somnolence, mainly at the start of treatment or when increasing the dose. If you experience these effects, do not drive or use machines.
Donepezil Tarbis contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again. The recommended dose is described below.
Donepezil is administered orally.
You should take donepezil once a day, orally with a glass of water in the evening, immediately before bedtime.
If you have abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend that you take donepezil in the morning.
The dose you take may vary depending on how long you have been taking the medicine and what your doctor recommends. Usually, treatment is started with a 5 mg tablet taken once a day with a little water, in the evening. After one month of treatment, your doctor may indicate an increase in the dose to 10 mg once a day and in the evening. The maximum recommended dose is 10 mg per day.
Both you and your caregivers should know the doctor's instructions.
If you have mild or moderate hepatic insufficiency (a disease that affects the liver) or renal insufficiency (a disease that affects the kidneys), you may follow a similar dosage regimen as indicated above.
If you take more Donepezil Tarbis than you should:
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone (91) 562 04 20, indicating the medicine and the amount ingested.
At high doses (overdose), adverse effects (see section 4 Possible side effects) may worsen. In particular, nausea, vomiting, salivation, sweating, slow heart rate, low blood pressure, difficulty breathing, collapse, seizures, and muscle weakness may occur.
If you forget to take Donepezil Tarbis:
If you forget to take a dose, take the forgotten dose as soon as possible. Unless it is time for the next dose.
Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Donepezil Tarbis 5mg film-coated tablets can cause side effects, although not everybody gets them. The estimated frequency of their occurrence is as follows:
Serious side effects:
You should inform your doctor immediately if you notice any of the following serious side effects, as you may need urgent medical treatment.
Very common side effects may affect more than 1 in 10 patients and are:
Common side effects may affect up to 1 in 10 patients and are:
Uncommon side effects may affect up to 1 in 100 patients and are:
Rare side effects may affect up to 1 in 1,000 patients and are:
Side effects of unknown frequency (cannot be estimated from the available data) are:
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the carton. The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Donepezil Tarbis 5 mg film-coated tablets
The active substance is donepezil hydrochloride monohydrate. Each film-coated tablet contains 5mg of donepezil hydrochloride equivalent to 4.56 mg of donepezil base.
The other ingredients are:
Core of the tablet
Coating
Appearance of the product and contents of the pack
Donepezil Tarbis 5 mg film-coated tablets are white, round, biconvex tablets marked 'DZ5'.
Each pack contains 28 and 50 (clinical pack) film-coated tablets in aluminum-PVC blisters or a PE bottle.
Donepezil Tarbis is also available in 10 mg film-coated tablets in packs of 28 and 50 (clinical pack) film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
TARBIS FARMA, S.L.
Gran Vía Carlos III, 94
Barcelona (Spain)
Manufacturer:
Actavis Limited
BLB016 Bulebel Industrial Estate
Zejtun, ZTN 3000
Malta
Date of last revision of this leaflet:October 2022
“Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/”
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DONEPEZIL TARBIS 5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.